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Transanal total mesorectal excision (taTME) is a new natural orifice translumenal endoscopic surgery modality combined of 
three rectal surgery techniques. Detailed analysis of the taTME is the object of this article. We submit the report of three taTME 
procedures for histologically confirmed rectal adenocarcinoma that were performed for the first time in Lithuania, Vilnius 
University Hospital Santariskiu Klinikos.
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Transanalinė totalinė mezorektalinė ekscizija (taTME) yra naujas endoskopinis natūralių angų chirurgijos būdas, susidedantis 
iš trijų tiesiosios žarnos chirurginių metodų. Šiame straipsnyje detaliai aprašoma taTME chirurginė technika bei pristatomos 
pirmosios trys taTME procedūros, kurios buvo atliktos Vilniaus universiteto ligoninėje Santariškių klinikose. 
Reikšminiai žodžiai: taTME, tiesiosios žarnos chirurgija, minimaliai invazinė chirurgija
Originalūs mokslo tiriamieji darbai
Introduction 
Laparoscopic assisted transanal total mesorectal excision 
(taTME) procedures are evolving as a part of minimally 
invasive surgery, which was firstly performed by Sylla, 
Rattner, Delgado, and Lacy in 2009 and published in 
2010 [1]. TaTME is a new natural orifice translumenal 
endoscopic surgery modality combined of three rectal 
surgery techniques – total mesorectal excision (TME), 
trans-anal trans-abdominal (TATA), and trans-anal 
endoscopic microsurgery (TEM) [2, 3]. The rectum is 
dissected transanally using the TME principles and it is 
called “down-to-up” TME [4]. The procedure poten-
tially solves some difculties in the pelvic part of the 
dissection, such as male pelvic outlet, high body mass 
index (BMI) or a short distance of locally advanced 
tumour from the anal verge and provides safer exposure 
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and better visual control for TME [5, 6]. This surgical 
technique presents wide resection margins, good quality 
of specimen after TME and may find special application 
in patients with anatomic constraints that could make 
laparoscopic TME highly challenging [7, 8].
We report the first three transanal total mesorectal 
excision procedures for histologically confirmed rectal 
adenocarcinoma, which were performed in Lithuania, 
Vilnius University Hospital Santariskiu Klinikos.
Patients 
Patients after colonoscopy with biopsy-proven rectal 
adenocarcinoma were selected for taTME procedure. 
The detailed information of the three our patients is 
described in table 1. All patients had a complete exami-
nation of disease outspread before operations. Thorough 
colonoscopy, pelvic magnetic resonance imaging (MRI), 
and thoracoabdominal computed tomography scan 
were performed. After that, multidisciplinary team deci-
sion was accepted. According to the preoperative MRI 
staging, neoadjuvant therapy was not indicated and 
neither of patients was treated. The taTME procedure 
was suggested and the patients gave informed consents 
for this surgical approach. 
Surgical technique
Under the general anaesthesia the patient is placed 
in the lithotomy position. TaTME is performed con-
comitantly by two teams. The abdominal and perineal 
operative fields are prepared for transabdominal and 
transanal access. 
Firstly, a small longitudinal incision is made above the 
umbilicus and the pneumoperitoneum of 12 mmHg is 
established using a Veress needle. 10-mm trocar is in-
serted and the abdominal cavity is explored to evaluate 
if the disease is not outspread and the case is suitable for 
laparoscopic assisted taTME procedure. After confirma-
tion, one 12-mm trocar is inserted in the right iliac fossa 
Table 1. Detailed information of the three patients
# 1 # 2 # 3
Gender female male male
Age (years) 66 41 83
BMI (kg/m2) 29.94 24.93 27.92
ASA 2 1 3
Comorbidity BA No HBP, CAF, COPD, BPH
Location of tumor 9 cm from AV 10 cm from AV 4 cm from AV
Diameter of tumor (cm) 2 × 2 × 1 1 × 1 × 1 5 × 3 × 2
TNM stage based on MRI T2N0M0 T2N0M0 T2N0M0
Neoadjuvant therapy No No No
OT (min) 285 210 340
Blood loss (ml) 10 0 400
Mobilization of splenic flexure No No No
Ileostomy Yes Yes Yes
Length of specimen (cm) 11.5 15 21
Harvested LN 10 12 18
pTNM stage pT2N0M0 pT1N0M0 pT3N0M0
CRM (cm) 3 1.8 2
Recover to flatus (days) 2 3 6
LOS (days) 8 8 18  
Abbreviations: BMI – body mass index, ASA – American Society of Anesthesiologists, BA – bronchial asthma, HBP – high 
blood pressure, CAF – chronic atrial fibrillation, COPD – chronic obstructive pulmonary disease, BPH – benign prostatic 
hyperplasia, AV – anal verge, MRI – magnetic resonance imaging, OT – operative time, LN – lymph nodes, CRM – circ-
umferential margin, LOS – length of hospital stay
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region and two other 10-mm trocars – in the right and 
left paraumbilical regions. 
The descending and sigmoid colon are mobilized 
from the lateral side while the left ureter is identified. In 
some patients, full mobilization of splenic flexure may 
be necessary. The high ligation of the inferior mesenteric 
vein and artery is performed intracorporally. 
At the same time, the anus is dilated and the flexible 
transanal port is inserted by the perineal team. SILS 
portTM (Covidien, Medtronic, Dublin, Ireland) with 
12-mm port for camera and two 5-mm working ports 
were used for the first two cases and TriPort® (Olympus, 
Europe Holding GmbH, Hamburg, Germany) was used 
for the third case. The pneumo-rectum (10–15 mmHg) 
is established and a purse-string PDS 3/0 suture is placed 
below the tumour under direct vision and tied securely 
Figure 5. End-to-end anastomosis formed laparoscopically
Figure 1. A purse-string suture distally to tumor and securely 
tied
Figure 2. A circularly incision of distal mucosa
Figure 3. Dissection of mesorectum
Figure 4. Extraperitonized bowel through the anus
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(Figure 1). Then, the distal mucosa is initially marked 
circularly using diathermy hook (Figure 2). After that, 
the dissection is performed using ultrasonic scalpel (Ul-
tracision ACETM, Ethicon Endo-Surgery, Cincinnati, 
OH, USA) starting inferiorly to superiorly (Figure 3). 
Posterior dissection is performed in front of the presacral 
fascia to preserve the mesorectal envelope. Anterior dis-
section is started when entering the rectovaginal septum 
for females and rectoprostatic plane for males. Lateral 
dissection connects the anterior and posterior planes 
bilaterally until the peritoneum is completely opened. 
After that, transanal device is removed. The transver-
sal 5 cm minilaparotomy above the pubic symphysis is 
performed and the rectum with sigmoid colon is extra-
peritonised (case no. 1 and case no. 3). In one case, we 
extraperitonised the proximal part of the colon through 
the anus (case no. 2) (Figure 4). Bowel resection is 
performed extracorporeally and the anvil of the stapler 
is inserted into the proximal colon. The purse-string 
suture is placed on the anvil for end-to-end stapler anas-
tomosis and the bowel is reinserted into the abdominal 
cavity. The transanal port is reinserted and pneumoperi-
toneum is restored. A purse-string suture is placed in the 
distal rectum stump through the transanal device and 
tied fully closing it. The shaft of a 31-mm AutoSuture 
CEEA® circular stapler (Covidien, Medtronic, Dublin, 
Ireland) is inserted through the anus and the end-to-
end stapler anastomosis is formed under laparoscopical 
visualisation (Figure 5). An intraoperative anastomotic 
water-air testing is performed and the drain is left in-
traabdominally. The preventative ileostomy is formed in 
the right paraumbilical port place. 
Results
The laparoscopic assisted taTME operations were per-
formed successfully (the operative technique is descri-
bed above). A temporary diverting loop ileostomy was 
performed for all patients. There were no intra-operative 
or postoperative complications recorded for the first 
two patients. The third patient had no intraoperative 
complications, but early postoperative period was 
eventful. Two days after the operation, the symptoms 
of intestinal obstruction appeared and the blood test 
revealed inflammatory activity, therefore, the conser-
vative treatment was indicated. Moreover, the urine 
retention due to benign prostate hyperplasia was obser-
ved and the percutaneous suprapubic cystostomy was 
performed. No further interventions were needed. The 
conservative treatment was successful and the patient 
was discharged on day 18 after the taTME procedure. 
The adjuvant therapy was not indicated for all patients. 
Recto-sigmoidoscopies and preventative ileostomies 
reversals were performed after 3 months. There was no 
evidence of local recurrences detected. 
Discussion
TME is the “gold standard” of surgical treatment for 
rectal cancer, firstly reported by Heald and Ryall [9]. 
Nevertheless, operating middle and lower third rectal 
tumours in open and laparoscopic TME, the positive 
circumferential resection margin (+CRM) remains high 
and is presented 10% in both groups in the COLLOR II 
trial [10]. 2 mm or less involvement of CRM is related 
with local recurrence risk of 16% compared with 5.8% 
in patients without involvement of CRM (p < 0.0001) 
[11]. The similar results are presented by Quirke et al. 
with local recurrence risk of 6% of negative CRM vs. 
17% of positive CRM [12]. Moreover, macroscopically 
incomplete specimen resections are similar and accounts 
for 3% in open or laparoscopic rectal surgery [10].
Knowing these relevant problems, a new technique 
was necessary to overcome such difculties. TaTME is a 
novel minimally invasive surgery technique for middle 
and lower rectal cancers. The procedure, described 
above, is challenging which requires pelvic anatomy 
knowledge, surgical practice in open and laparoscopic 
TME, and transanal endoscopic surgery skills [13]. The 
factors that suggest taTME as a preferable approach 
are: a) male gender, b) middle and lower rectal cancer, 
c) narrow and/or deep pelvis, d) high BMI, e) beni-
gn prostatic hyperplasia, f ) tumour diameter >4 cm, 
g) deformed tissues due to neoadjuvant radiotherapy, 
h) low tumour requiring careful placement of the distal 
resection margin (DRM) [14].
Recently, Simmilis et al. presented a systematic review 
of 510 taTME cases and calculated 5% CRM involve-
ment and 0.3% DRM positivity [15]. Moreover, there 
are other large studies after this systematic review with 
similar results. Helbach et al. introduced 80 patients 
with 2.5% CRM involvement and 0% DRM involve-
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ment after taTME [16]. Lacy et al. published the largest 
prospective study with 140 patients who underwent ta-
TME. The 9 patients (6.4%) had involved CRM, which 
were diagnosed preoperatively correctly with MRI and 
had a complete mesorectal specimen after the operation 
[17]. Burke et al. showed a 4% CRM positivity and 2% 
DRM positivity of 50 patients’ study [18]. We think 
these results are promising. 
Moreover, taTME was developed to overcome tech-
nical difculties associated with open and laparoscopic 
TME [2]. The most common technical problems, as 
mentioned above, are a large tumour, located in the 
lower third rectum, obesity or narrow pelvis. During ta-
TME, it is better to visualize the presacral and perirectal 
planes as an unobstructed view [5, 6]. Simillis et al. 
reported two full studies comparing taTME vs. laparos-
copic TME [15]. Complete mesorectum (96% vs. 72%, 
p < 0.05), surgical time (215 ± 60 minutes vs. 252 ± 
50 minutes, p < 0.01), coloanal anastomosis rate (43% 
vs. 16%, p = 0.01), 30-day postoperative complication 
rate (32% vs. 51%, p = 0.16), early readmissions (6% 
vs. 22%, p = 0.03) were better in taTME comparing to 
traditional laparoscopic TME [19, 20]. The first results 
demonstrate comparable short-term results for taTME 
and traditional laparoscopic TME. To improve promi-
sing results, the ongoing COLLOR III randomized trial 
compares taTME and laparoscopic TME for mid and 
low rectal carcinomas [21]. 
Our experience is three patients with successful ta-
TME procedures and postoperative treatment. Howe-
ver, patients’ number for further significant conclusions 
is too small. Successful experience and promising results 
encourages us to continue the started work in taTME 
surgery.
Conclusions
TaTME is a feasible approach with promising results, 
especially for obese, male patients with middle and 
lower third rectal carcinomas.
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